- Home
- IMUX vs WIMI Comparison
IMUX vs WIMI Comparison
Compare IMUX & WIMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IMUX | WIMI |
|---|---|---|
| Founded | 2016 | 2015 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 85.8M | 38.3M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | IMUX | WIMI |
|---|---|---|
| Price | $0.62 | $2.95 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | ★ 1.2M | 76.0K |
| Earning Date | 11-13-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.43 |
| Revenue | N/A | ★ $61,329,146.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $2.03 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.56 | $2.24 |
| 52 Week High | $1.39 | $9.66 |
Technical Indicators
Market Signals| Indicator | IMUX | WIMI |
|---|---|---|
| Relative Strength Index (RSI) | 36.87 | 39.62 |
| Support Level | $0.66 | $2.77 |
| Resistance Level | $0.70 | $3.26 |
| Average True Range (ATR) | 0.04 | 0.16 |
| MACD | -0.00 | 0.04 |
| Stochastic Oscillator | 1.40 | 28.56 |
Price Performance
Historical ComparisonAbout IMUX Immunic Inc.
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.
About WIMI WiMi Hologram Cloud Inc.
WiMi Hologram Cloud Inc and its subsidiaries offer augmented reality (AR) based holographic services and products to cater to its customers. Its AR service and product offerings consist of holographic AR advertising services and holographic AR entertainment products. It is also into the semiconductor business, in which the company provides central processing algorithm services and computer chip products to enterprise customers and the sales of comprehensive solutions for central processing algorithms and related services with software and hardware integration. The company reports in three segments: AR advertising, AR entertainment, and Semiconductor. Its geographical segments are Mainland China, Hong Kong, and International.